About the Course

The Fundamentals of HCT Training Course provides a broad overview and introduction of hematopoietic cell transplantation (HCT) and cellular immunotherapy (CI). Throughout the lectures, participants are introduced to numerous aspects of the HCT-CI processes, which are designed to develop or enhance skills required in the management of patients undergoing these procedures. This course incorporates case-based learning to emphasize application of concepts taught through didactic lecture with a strong focus on pharmacotherapeutic management. For any questions about the course or registration, please contact info@astct.org. 

In 2026, attendees were able to earn up to 15.0 continuing education credits. 

Who Should Attend

  • Advanced Practice Providers
  • Fellows
  • In-Training Professionals
  • New Practitioners
  • Nurses
  • Pharmacists
  • Physicians
  • Residents

Key Information

  • Deadline to register: April 8, 2026 at 5 PM CT
  • Attendees can earn up to 15.0 CE for sessions attended in real-time
  • Access session recordings through May 10, 2026

Registration

Registration for the 2026 Fundamentals of HCT Training Course is now open. 

Register

Registration Rates
Category

Early Bird Price
(January 14-February 25)

Standard Price
(February 26-April 8)
ASTCT Member Rate $275 $350
Non-Member Rate $375 $450
Fellow/Trainee Rate $225 $300
Low-Middle Income Countries Rate* $30 $30
2025 Fundamentals of HCT eBook** $150

 

*Only eligible for registrants currently practicing and residing in a low-middle income country as classified by the World Bank here.

**With this add-on, you will receive access to the 2025 Fundamentals of HCT eBook. Please advise that the eBook is NOT required to attend the meeting or participate in any of the live sessions.

Attendees will have access to the virtual platform until May 10, 2026, to review recordings, but please note that to obtain ACPE credit, AMA PRA Category 1 Credit(s), and ANCC contact hours, you must attend the live sessions on April 9-10, 2026. Recordings are only available to view on the virtual platform. Attendees are unable to download the session recordings for personal viewing, but you will be able to download PDFs of speaker slides. Please review the full accreditation information at the bottom of this page for instructions on participation and requesting credit.

Cancellation Policy

Registered attendees will have access to the recordings until May 10, 2026. Therefore, ASTCT will not be refunding any registrations to the 2026 Fundamentals of HCT Training Course. Registration payments are non-transferable.

Agenda

Day 1: Thursday, April 9, 2026 (CDT)
 
Time Topic
8:00 – 8:10 AM
(10 mins)		 Welcome & Opening Remarks
Kendall Shultes, PharmD, BCOP
8:10 – 8:55 AM
(45 mins) – 0.75		 Introduction to Hematopoietic Cell Transplantation
Jason Ernstberger, PharmD, BCOP; University of Cincinnati Medical Center, Cincinnati, OH
9:00 – 10:00 AM
(60 mins) – 1.0		 Donor Selection and Introduction to HLA Typing
Adult – Shatha Farhan, MD; Henry Ford Health System, Detroit, MI
Pediatric – Anand Srinivasan, MBBS; Mayo Clinic, Rochester, MN
10:00 – 10:10 AM
(10 mins)		 Break
10:10 – 11:10 AM
(60 mins) – 1.0		 Principles of Conditioning in Hematopoietic Cell Transplantation
Binni Kunvarjee, PharmD, BCOP; Memorial Sloan Kettering Cancer Center, New York, NY
11:15 AM – 12:15 PM
(60 mins) – 1.0

Supportive Care for Peri-Transplant Complications 
Amber Clemmons, PharmD, BCOP, FHOPA; Wellstar-MCG Health Medical Center, Augusta, GA 
12:15 – 12:35 PM
(20 mins)		 Lunch
12:35 – 1:20 PM
(45 mins) – 0.75		 Special Populations in HCT: Pediatrics
Susie Long, PharmD; University of Minnesota Masonic Children’s Hospital, Minneapolis, MN		 Special Populations in HCT: Geriatrics
Andrew Artz, MD, MS; City of Hope, Duarte, CA
1:25 – 2:10 PM
(45 mins) – 0.75		 Caring for the AYA HCT Patient: It takes a Village – Interdisciplinary Panel 
Stephanie Fooks-Parker MSW, LSW, OSW-C; Social Worker, Children’s Hospital of Philadelphia, Philadelphia, PA
Tiffany Harmer, BSN, RN; Cellular Therapy & BMT Nurse Coordinator, Huntsman Cancer Institute, Salt Lake City, UT
Cory Edgar, DMSc, PA-C; Director of Survivorship, Advent Health, Orlando, FL 
2:10 – 2:20 PM
(10 mins)		 Break
2:20 – 3:20 PM
(60 mins) – 1.0 		 Immune Effector Cell Products and Indications
Jennifer Collins, PharmD, BCOP; University of Chicago Medicine, Chicago, IL
3:25 – 4:25 PM
(60 mins) – 1.0 		 Immune Effector Cell Management of Toxicities and Complications
Cameron Ninos, PharmD, BCOP; University of Wisconsin–Madison, Madison, WI
4:25 – 4:55 PM
(30 mins)		 Virtual Roundtable Discussion & Wrap-Up (*No CE provided)
Total Credit for Day 1 = 7.25
Day 2: Friday, April 10, 2026 (CDT)
Time Topic
8:00 – 9:00 AM
(60 mins) – 1.0 		 Fungal Infections in Hematopoietic Cell Transplantation
Aliyah Baluch, MD; Moffitt Cancer Center, Tampa, FL 
9:05 – 10:05 AM
(60 mins) – 1.0 		 Viral Infections in Hematopoietic Cell Transplantation
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, FASTCT; Atrium Health Wake Forest Baptist, Winston-Salem, NC 
10:05 – 10:15 AM
(10 mins)		 Break
10:15 – 11:00 AM
(45 mins) – 0.75		 Thrombotic Microangiopathy in Hematopoietic Cell Transplantation 
Hemalatha Rangarajan, MD; Nationwide Children's Hospital, Columbus, OH 		 Veno Occlusive Disease/Sinusoidal Obstructive Syndrome 
Teresa Rushing, PharmD, BCPS, BCOP; Children’s Hospital Los Angeles, Los Angeles, CA 
11:05 AM – 12:20 PM
(75 mins)  – 1.25		 Acute Graft versus Host Disease
Elizabeth DiMaggio, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL
12:20 – 12:30 PM
(10 mins)		 Lunch
12:30 – 1:45 PM
(75 mins) – 1.25		 Chronic Graft versus Host Disease
Rebecca Gonzalez, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL
1:45 – 1:55 PM
(10 mins)		 Break
1:55 – 2:40 PM
(45 mins) – 0.75		 Patient Case: Rare Complications Post-IEC Therapy: Neurological Toxicity and GI Enterocolitis 
Bettina Zerante, APP; University of Chicago Medical Center, Chicago, IL 		 Patient Case: Navigating Cytopenias Post Transplant and Graft Failure 
Forat Lutfi, MD; University of Kansas Medical Center, Westwood, KS
 
2:45 – 3:45 PM
(60 mins) – 1.0

Tumor Infiltrating Lymphocytes and T-Cell Receptor Therapy for Solid Tumors 
Daniel Olson, MD; University of Chicago Medical Center, Chicago, IL
3:45 – 3:55 PM
(10 mins) 		 Break
3:55 – 4:40 PM
(45 mins) – 0.75

Cellular Therapy and Gene Therapy for Non-Malignant Indications 
Christine Duncan, MD; Boston Children’s Cancer and Blood Disorders Center, Boston, MA
4:40 – 5:10 PM
(30 mins)		 Virtual Roundtable Discussion & Wrap-Up (*No CE provided)
Total Credit for Day 2 = 7.75

Accredited Provider

This activity is jointly provided by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). Attendees can earn up to 15.0 continuing education credits or hours.

 

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION

The France Foundation designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

The France Foundation designates this activity for 15.0 contact hours.

PHARMACISTS

This knowledge and application-based activity qualifies for 15.0 contact hours (0.150 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net)

All other healthcare professionals completing this course will be issued a statement of participation.

COURSE SYLLABUS

The course syllabus for the conference will be available closer to the conference dates. 

DISCLOSURE POLICY
The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and ASTCT resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and ASTCT seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ASTCT are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

Disclosures for members of the planning committee and faculty will be available closer to the conference dates. 

Disclosure of Unlabeled Use:
The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require CE faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational. They must also disclose limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off label use of these medications. TFF and ASTCT do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

ASTCT is not seeking commercial support to assist in funding this live education opportunity.

Disclaimer
The France Foundation and the American Society for Transplantation and Cellular Therapy present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, The American Society for Transplantation

CONTACT INFORMATION
If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.